the declared strategic target is Sepsi snd E Coli with a bonus of topical spay anti bacterial wound infection so why are some posters focussing on antiviral properties of RCE products.
if 327 also combats the flesh eating bacteria all well and good.
can we stay on topic?
Ann: R327 to Stage 2 of SARS-CoV-2 Antiviral Screening at CSIRO, page-66
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $86.51M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 29.0¢ | $37.22K | 127.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8471 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 17050 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |